These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6189445)

  • 1. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
    Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H
    Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group Study.
    Livingston RB; Helibrun L; Lehane D; Costanzi JJ; Bottomley R; Palmer RL; Stuckey WJ; Hoogstraten B
    Cancer Treat Rep; 1977 Dec; 61(9):1623-9. PubMed ID: 74281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Lester EP; Kinnealey A; Matz GJ
    Laryngoscope; 1979 Dec; 89(12):1921-9. PubMed ID: 92740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
    Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR
    Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
    Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
    Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.
    Davis S; Rambotti P; Park YK
    Cancer Treat Rep; 1981; 65(11-12):955-8. PubMed ID: 7028257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
    Corral DA; Sella A; Pettaway CA; Amato RJ; Jones DM; Ellerhorst J
    J Urol; 1998 Nov; 160(5):1770-4. PubMed ID: 9783949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy in squamous cell carcinoma of the lung.
    Krzakowski MJ; Swierz J
    Chemioterapia; 1984 Apr; 3(2):75-8. PubMed ID: 6085285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Veronesi A; Magri MD; Trovò MG; Tirelli U; Galligioni E; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Oct; 66(10):1877-8. PubMed ID: 6181871
    [No Abstract]   [Full Text] [Related]  

  • 15. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
    Pouillart P; Palangie T; Garcia-Giralt E; Jouve M; Bataini JP; Jaulerry M; Brugère J; Asselin B
    Bull Cancer; 1980; 67(3):269-80. PubMed ID: 6157447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
    Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results].
    Pipino G; Germiniani R; Maione G; Fazio FM
    Arch Sci Med (Torino); 1983; 140(2):135-8. PubMed ID: 6192792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.